BridgeBio Pharma, Inc.

NasdaqGS:BBIO Stock Report

Market Cap: US$4.8b

BridgeBio Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:BBIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Jul 23SellUS$52,500,000Viking Global Investors LPCompany1,500,000US$35.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BBIO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8,2170.00439%
Individual Insiders9,696,7145.18%
General Public10,388,9095.55%
Hedge Funds25,120,99113.4%
VC/PE Firms31,060,97116.6%
Institutions110,853,45859.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.6%.


Top Shareholders

Top 25 shareholders own 74.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.6%
KKR & Co. Inc.
31,060,971US$795.8m0%5.62%
13.4%
Viking Global Investors LP
25,120,991US$643.6m0%2.26%
6.84%
The Vanguard Group, Inc.
12,800,294US$327.9m13.5%0.01%
5.43%
BlackRock, Inc.
10,156,773US$260.2m9.8%no data
3.67%
Neil Kumar
6,875,932US$176.2m0.8%no data
3.24%
Aisling Capital Management LP
6,068,125US$155.5m0%62.45%
2.8%
Laurion Capital Management LP
5,241,833US$134.3m-7.24%4.75%
2.72%
State Street Global Advisors, Inc.
5,086,899US$130.3m0.92%0.01%
1.79%
Cormorant Asset Management, LP
3,344,179US$85.7m-28.3%4.69%
1.66%
Lord, Abbett & Co. LLC
3,098,082US$79.4m290%0.25%
1.52%
Goldman Sachs Group, Investment Banking and Securities Investments
2,835,606US$72.6m187%0.04%
1.48%
Pictet Asset Management Limited
2,767,185US$70.9m0.99%0.05%
1.46%
Frazier Life Sciences Management, LP
2,725,949US$69.8m0%3.11%
1.45%
Geode Capital Management, LLC
2,714,168US$69.5m8.08%0.01%
1.37%
AllianceBernstein L.P.
2,557,416US$65.5m-5.84%0.02%
1.29%
FMR LLC
2,414,255US$61.9m-0.54%no data
1.12%
T. Rowe Price Group, Inc.
2,093,642US$53.6m98%no data
0.99%
Sequoia Capital Operations LLC
1,860,364US$47.7m0%0.23%
0.93%
Perceptive Advisors LLC
1,748,933US$44.8m0%1.02%
0.88%
UBS Asset Management AG
1,645,728US$42.2m94%0.01%
0.83%
Citigroup Inc.,Banking and Securities Investments
1,557,231US$39.9m-1.91%0.04%
0.8%
Wellington Management Group LLP
1,495,114US$38.3m5.32%0.01%
0.76%
Morgan Stanley, Investment Banking and Brokerage Investments
1,415,207US$36.3m14.7%no data
0.74%
Hillhouse Investment Management, Ltd.
1,391,240US$35.6m-50%0.2%
0.66%
Charles Homcy
1,230,085US$31.5m0.25%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.